| European Case Law Identifier: | ECLI:EP:BA:2005:T034301.20050512 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 12 May 2005 | ||||||||
| Case number: | T 0343/01 | ||||||||
| Application number: | 90916891.6 | ||||||||
| IPC class: | C12P 7/64 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Process for the heterotrophic production of products with high concentrations of Omega-3 highly unsaturated fatty acids | ||||||||
| Applicant name: | Mertek Biosciences Corporation | ||||||||
| Opponent name: | 01. Nagase Biochemicals, Ltd 02. Aventis Research & Technologies GmbH |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Right to be heard violated (yes) Substantial procedural violation (yes) Remittal to the first instance (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t010343eu1.html
Date retrieved: 17 May 2021